Histamine signalling in Schistosoma mansoni: Immunolocalisation and characterisation of a new histamine-responsive receptor (SmGPR-2)

International Journal for Parasitology

Volumn 40, Issue 12, 2010, Pages 1395-1406

  El Shehabi, Fouad ^a   Ribeiro, Paula ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Biogenic amines; Confocal immunofluorescence; GPCR; Histamine; Neurotransmitter; Platyhelminthes; Receptor; Schistosoma mansoni

Indexed keywords

BIOGENIC AMINE; COMPLEMENTARY DNA; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 2; HISTAMINE; HISTAMINE RECEPTOR; RNA; TELE METHYLHISTAMINE; UNCLASSIFIED DRUG;

BIOGENIC MATERIAL; CLONE; GENE EXPRESSION; GENETIC ANALYSIS; IMMUNOASSAY; METABOLISM; MOTILITY; NERVOUS SYSTEM; PARASITE; REPRODUCTION;

ARTICLE; CERCARIA (TREMATODE LARVA); CONTROLLED STUDY; GENE EXPRESSION REGULATION; HISTAMINE METABOLISM; IMMUNOLOCALIZATION; LARVA; MOLECULAR CLONING; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL NERVOUS SYSTEM; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE; SCHISTOSOMA MANSONI; SIGNAL TRANSDUCTION; SNAIL;

AMINO ACID SEQUENCE; ANIMALS; CLONING, MOLECULAR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HELMINTH PROTEINS; HISTAMINE; LARVA; MOLECULAR SEQUENCE DATA; NERVOUS SYSTEM; PHYLOGENY; PROTEIN TRANSPORT; RECEPTORS, HISTAMINE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; SUBMUCOUS PLEXUS;

MAMMALIA; PLATYHELMINTHES; SACCHAROMYCES CEREVISIAE; SCHISTOSOMA MANSONI;

EID: 78951484738     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2010.04.006     Document Type: Article

References (70)

1. Ballesteros J., Palczewski K. G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin. Curr. Opin. Drug Discov. Dev. 2001, 4:561-574.
2. Ballesteros J.A., Weinstein H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein coupled receptors. Method Neurosci. 1995, 25:366-428.
3. Basch P.F. Cultivation of Schistosoma mansoni in vitro. I. Establishment of cultures from cercaria and development until pairing. J. Parasitol. 1981, 67:179-185.
4. Basch P.F., Humbert R. Cultivation of Schistosoma mansoni in vitro. III. Implantation of cultured worms into mouse mesenteric veins. J. Parasitol. 1981, 67:191-195.
5. Befort K., Zilliox C., Filliol D., Yue S., Kieffer B.L. Constitutive activation of the delta opioid receptor by mutations in transmembrane domains III and VII. J. Biol. Chem. 1999, 274:18574-18581.
6. Berriman M., Haas B.J., LoVerde P.T., Wilson R.A., Dillon G.P., Cerqueira G.C., Mashiyama S.T., Al-Lazikani B., Andrade L.F., Ashton P.D., Aslett M.A., Bartholomeu D.C., Blandin G., Caffrey C.R., Coghlan A., Coulson R., Day T.A., Delcher A., DeMarco R., Djikeng A., Eyre T., Gamble J.A., Ghedin E., Gu Y., Hertz-Fowler C., Hirai H., Hirai Y., Houston R., Ivens A., Johnston D.A., Lacerda D., Macedo C.D., McVeigh P., Ning Z., Oliveira G., Overington J.P., Parkhill J., Pertea M., Pierce R.J., Protasio A.V., Quail M.A., Rajandream M.A., Rogers J., Sajid M., Salzberg S.L., Stanke M., Tivey A.R., White O., Williams D.L., Wortman J., Wu W., Zamanian M., Zerlotini A., Fraser-Liggett C.M., Barrell B.G., El-Sayed N.M. The genome of the blood fluke Schistosoma mansoni. Nature 2009, 460:352-358.
7. Boess F.G., Monsma F.J., Sleight A.J. Identification of residues in transmembrane regions III and VI that contribute to the ligand binding site of the serotonin 5-HT6 receptor. J. Neurochem. 1998, 71:2169-2177.
8. Bond R.A., Ijzerman A.P. Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery. Trends Pharmacol. Sci. 2006, 27:92-96.
9. Boyle J.P., Yoshino T.P. Serotonin-induced muscular activity in Schistosoma mansoni larval stages: importance of 5HT transport and role in daughter sporocyst production. J. Parasitol. 2005, 91:542-550.
10. Cannon M. The KSHV and other human herpesviral G protein-coupled receptors. Curr. Top. Microbiol. Immunol. 2007, 312:137-156.
11. Catto B.A., Lewis F.A., Ottesen E.A. Cercaria-induced histamine release: a factor in the pathogenesis of schistosome dermatitis?. Am. J. Trop. Med. Hyg. 1980, 29:886-889.
12. Choudhary M.S., Craigo S., Roth B.L. A single point mutation (Phe340→Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2 receptors. Mol. Pharmacol. 1993, 43:755-761.
13. Cikos S., Bukovska A., Koppel J. Relative quantification of mRNA: comparison of methods currently used for real-time PCR data analysis. BMC Mol. Biol. 2007, 8:113.
14. Day T.A., Bennett J.L., Pax R.A. Serotonin and its requirement for maintenance of contractility in muscle fibers isolated from Schistosoma mansoni. Parasitology 1994, 108:425-432.
15. Dowell S.J., Brown A.J. Yeast assays for G-protein-coupled receptors. Receptors Channels 2002, 8:343-352.
16. Eglen R.M. Emerging concepts in GPCR function-the influence of cell phenotype on GPCR pharmacology. Proc. West Pharmacol. Soc. 2005, 48:31-34.
17. El-Shehabi F., Vermeire J., Timothy P., Yoshino T.P.R. Developmental expression analysis and immunolocalization of a biogenic amine receptor in Schistosoma mansoni. Exp. Parasitol. 2009, 122:17-27.
18. Ercoli N., Payares G., Nunez D. Schistosoma mansoni: neurotransmitters and the mobility of cercaria and schistosomules. Exp. Parasitol. 1985, 59:204-216.
19. Eriksson K.S., Johnston R.N., Shaw C., Halton D.W., Panula P.A. Widespread distribution of histamine in the nervous system of a trematode flatworm. J. Comp. Neurol. 1996, 373:220-227.
20. Fallon P.G., Doenhoff M.J. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am. J. Trop. Med. Hyg. 1994, 51:83-88.
21. Gerken S.E., Mota-Santos T.A., Vaz N.M., Correa-Oliveira R., Dias-da-Silva W., Gazzinelli G. Recovery of schistosomula of Schistosoma mansoni from mouse skin: involvement of mast cells and vasoactive amines. Braz. J. Med. Biol. Res. 1984, 17:301-307.
22. Gietz R.D., Schiestl R.H., Willems A.R., Woods R.A. Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. Yeast 1995, 11:355-360.
23. Hamdan F.F., Ribeiro P. Characterization of a stable form of tryptophan hydroxylase from the human parasite Schistosoma mansoni. J. Biol. Chem. 1999, 274:21746-21754.
24. Hamdan F.F., Abramovitz M., Mousa A., Xie J., Durocher Y., Ribeiro P. A novel Schistosoma mansoni G protein-coupled receptor is responsive to histamine. Mol. Biochem. Parasitol. 2002, 119:75-86.
25. Hoffmann K.F., Davis E.M., Fischer E.R., Wynn T.A. The guanine protein coupled receptor rhodopsin is developmentally regulated in the free-living stages of Schistosoma mansoni. Mol. Biochem. Parasitol. 2001, 112:113-123.
26. Huang P., Chen C. Molecular mechanisms involved in the activation of rhodopsin-like seven-transmembrane receptors. The G Protein-Coupled Receptors Handbook 2005, 33-70. Humana Press Inc., New Jersey, USA, (Chapter 2). L.A. Devi, A. Engel, K. Palczewski (Eds.).
27. Ismail M.M., Taha S.A., Farghaly A.M., el-Azony A.S. Laboratory induced resistance to praziquantel in experimental schistosomiasis. J. Egypt Soc. Parasitol. 1994, 24:685-695.
28. Jongejan A., Lim H.D., Smits R.A., de Esch I.J., Haaksma E., Leurs R. Delineation of agonist binding to the human histamine H4 receptor using mutational analysis, homology modeling, and ab initio calculations. J. Chem. Inf. Model. 2008, 48:1455-1463.
29. Kimber M.J., Sayegh L., El-Shehabi F., Song C., Zamanian M., Woods D.J., Day T.A., Ribeiro P. Identification of an Ascaris G protein-coupled acetylcholine receptor with atypical muscarinic pharmacology. Int. J. Parasitol. 2009, 39:1215-1222.
30. Kristiansen K., Kroeze W.K., Willins D.L., Gelber E.I., Savage J.E., Glennon R.A., Roth B.L. A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT(2A) serotonin receptor but does not participate in activation via a "salt-bridge disruption" mechanism. J. Pharmacol. Exp. Ther. 2000, 293:735-746.
31. Ladds G., Goddard A., Davey J. Functional analysis of heterologous GPCR signaling pathways in yeast. Trends Biotechnol. 2005, 23:367-373.
32. Leurs C., Jansen M., Pollok K.E., Heinkelein M., Schmidt M., Wissler M., Lindemann D., Von Kalle C., Rethwilm A., Williams D.A., Hanenberg H. Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells. Hum. Gene Ther. 2003, 14:509-519.
33. Lewis F.A., Stirewalt M.A., Souza C.P., Gazzinelli G. Large-scale laboratory maintenance of Schistosoma mansoni, with observations on three schistosome/snail host combinations. J. Parasitol. 1986, 72:813-829.
34. Lewis F.A., Patterson C.N., Knight M., Richards C.S. The relationship between Schistosoma mansoni and Biomphalaria glabrata: genetic and molecular approaches. Parasitology 2001, 123(Suppl.):S169-S179.
35. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
36. Mair G.R., Maule A.G., Day T.A., Halton D.W. A confocal microscopical study of the musculature of adult Schistosoma mansoni. Parasitology 2000, 121(Pt. 2):163-170.
37. Mair G.R., Maule A.G., Fried B., Day T.A., Halton D.W. Organization of the musculature of schistosome cercaria. J. Parasitol. 2003, 89:623-625.
38. Mansour A., Meng F., Meador-Woodruff J.H., Taylor L.P., Civelli O., Akil H. Site-directed mutagenesis of the human dopamine D2 receptor. Eur. J. Pharmacol. 1992, 227:205-214.
39. Massotte D., Kieffer B. Structure-function relationships in G protein-coupled receptors: ligand binding and receptor activation. The G Protein-Coupled Receptors Handbook 2005, 3-31. Humana Press Inc., NJ, (Chapter 1). L.A. Devi (Ed.).
40. Maule A., Marks N., Day T. Signaling molecules and nerve-muscle function. Parasitic Flatworms: Molecular Biology, Biochemistry, Immunology and Physiology 2006, 369-386. CABI Publishing, UK, (Chapter 19). A. Maule, N. Marks (Eds.).
41. Mettrick D.F., Telford J.M. Histamine in the phylum platyhelminthes. J. Parasitol. 1963, 49:653-656.
42. Muntasir H.A., Takahashi J., Rashid M., Ahmed M., Komiyama T., Hossain M., Kawakami J., Nashimoto M., Nagatomo T. Site-directed mutagenesis of the serotonin 5-Hydroxytryptamine2c receptor: identification of amino acids responsible for sarpogrelate binding. Biol. Pharm. Bull. 2006, 29:1645-1650.
43. Nonaka H., Otaki S., Ohshima E., Kono M., Kase H., Ohta K., Fukui H., Ichimura M. Unique binding pocket for KW-4679 in the histamine H1 receptor. Eur. J. Pharmacol. 1998, 345:111-117.
44. Ohta K., Hayashi H., Mizuguchi H., Kagamiyama H., Fujimoto K., Fukui H. Site-directed mutagenesis of the histamine H1 receptor: roles of aspartic acid107, asparagine198 and threonine194. Biochem. Biophys. Res. Commun. 1994, 203:1096-1101.
45. Patocka N., Ribeiro P. Characterization of a serotonin transporter in the parasitic flatworm, Schistosoma mansoni: cloning, expression and functional analysis. Mol. Biochem. Parasitol. 2007, 154:125-133.
46. Pax R.A., Day T.A., Miller C.L., Bennett J.L. Neuromuscular physiology and pharmacology of parasitic flatworms. Parasitology 1996, 113(Suppl.):S83-S96.
47. Pearson M.S., McManus D.P., Smyth D.J., Jones M.K., Sykes A.M., Loukas A. Cloning and characterization of an orphan seven transmembrane receptor from Schistosoma mansoni. Parasitology 2007, 134:2001-2008.
48. Perez-Keep O., Payares G. Histoquimica de la cercaria de Schistosoma mansoni. Determinaci6n de la histamina e histaminoxidasa. Acta Cientifica Venezolana 1978, 29(Suppl. l):147.
49. Porter J.E., Hwa J., Perez D.M. Activation of the alpha1b-adrenergic receptor is initiated by disruption of an interhelical salt bridge constraint. J. Biol. Chem. 1996, 271:28318-28323.
50. Rao K.V., Chen L., Gnanasekar M., Ramaswamy K. Cloning and characterization of a calcium-binding, histamine-releasing protein from Schistosoma mansoni. J. Biol. Chem. 2002, 277:31207-31213.
51. Ribeiro P., El-Shehabi F., Patocka N. Classical transmitters and their receptors in flatworms. Parasitology 2005, 131(Suppl.):S19-S40.
52. Ribeiro P., Geary T.G. Neuronal signaling in schistosomes: current status and prospects for postgenomics. Can. J. Zool. 2010, 88:1-22.
53. Robb S.M.C., Ross E., Sánchez Alvarado A. SmedGD: the Schmidtea mediterranea genome database. Nucleic Acids Res. 2007, 36:D599-D606.
54. Roth B., Kristiansen K. Molecular mechanisms of ligand binding, signaling and regulation within the superfamily of G protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol. Ther. 2004, 103:21-80.
55. Roth B.L. The Serotonin Receptors: From Molecular Pharmacology to Human Therapeutics 2006, Humana Press Inc., NJ.
56. Shi L., Javitch J.A. The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop. Annu. Rev. Pharmacol. Toxicol. 2002, 42:437-467.
57. Stevenson B.J., Rhodes N., Errede B., Sprague G.F. Constitutive mutants of the protein kinase STE11 activate the yeast pheromone response pathway in the absence of the G protein. Genes Dev. 1992, 6:1293-1304.
58. Strader C.D., Sigal I.S., Register R.B., Candelore M.R., Rands E., Dixon R.A. Identification of residues required for ligand binding to the beta-adrenergic receptor. Proc. Natl. Acad. Sci. USA 1987, 84:4384-4388.
59. Strader C.D., Gaffney T., Sugg E.E., Candelore M.R., Keys R., Patchett A.A., Dixon R.A. Allele-specific activation of genetically engineered receptors. J. Biol. Chem. 1991, 266:5-8.
60. Sukhdeo M.V., Hsu S.C., Thompson C.S., Mettrick D.F. Hymenolepis diminuta: behavioral effects of 5-hydroxytryptamine, acetylcholine, histamine and somatostatin. J. Parasitol. 1984, 70:682-688.
61. Taman, A., Ribeiro, P., 2009. Investigation of a dopamine receptor in Schistosoma mansoni: functional studies and immunolocalization. Mol. Biochem. Parasitol.
62. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol 2007, 24:1596-1599.
63. The Schistosoma japonicum genome reveals features of host-parasite interplay. Nature 2009, 460:345-351. The Schistosoma japonicum Genome Sequencing and Functional Analysis Consortium.
64. Vischer H.F., Hulshof J.W., de Esch I.J., Smit M.J., Leurs R. Virus-encoded G-protein-coupled receptors: constitutively active (dys)regulators of cell function and their potential as drug target. Ernst Schering Found. Symp. Proc. 2006, 2:187-209.
65. Walker R.J., Brooks H.L., Holden-Dye L. Evolution and overview of classical transmitter molecules and their receptors. Parasitology 1996, 113(Suppl.):S3-S33.
66. Wang Z., Broach J.R., Peiper S.C. Functional expression of CXCR4 in Saccharomyces cerevisiae in the development of powerful tools for the pharmacological characterization of CXCR4. Methods in Molecular Biology: Transmembrane Signaling Protocols 2006, vol. 332:115-127. Humana Press Inc., NJ.
67. Wikgren M., Reuter M., Gustafsson M.K., Lindroos P. Immunocytochemical localization of histamine in flatworms. Cell Tissue Res. 1990, 260:479-484.
68. William S., Botros S., Ismail M., Farghally A., Day T.A., Bennett J.L. Praziquantel-induced tegumental damage in vitro is diminished in schistosomes derived from praziquantel-resistant infections. Parasitology 2001, 122(Pt. 1):63-66.
69. Wise A., Gearing K., Rees S. Target validation of G-protein coupled receptors. Drug Discov. Today 2002, 7:235-246.
70. Yonge K.A., Webb R.A. Uptake and metabolism of histamine by the rat tapeworm Hymenolepis diminuta: an in vitro study. Can. J. Zool. 1992, 70:43-50.